0000000000798514

AUTHOR

Elżbieta Rypulak

showing 2 related works from this author

MOESM1 of Influence of Early versus Late supplemental ParenteraL Nutrition on long-term quality of life in ICU patients after gastrointestinal oncolo…

2019

Additional file 1. SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents.

researchProduct

Influence of Early versus Late supplemental ParenteraL Nutrition on long-term quality of life in ICU patients after gastrointestinal oncological surg…

2019

Abstract Background Nutrition plays a major role in intensive care unit (ICU) treatment, influencing ICU length of stay and patient’s survival. If preferable enteral nutrition administration is not feasible, ESPEN and ASPEN guidelines recommend initiation of a supplemental parenteral route between the first and seventh day, but exact timing remains elusive. While rapid development in critical care enabled significant reduction in the mortality rate of ICU patients, this improvement also tripled the number of patients going to rehabilitation. Thus, it is quality of life after ICU that has become the subject of interest of clinicians and healthcare policy-makers. A growing body of evidence in…

Adultmedicine.medical_specialtyParenteral NutritionCritical IllnessPopulationMedicine (miscellaneous)law.inventionTime03 medical and health sciencesStudy Protocol0302 clinical medicineQuality of lifeRandomized controlled triallawEarly Medical InterventionClinical endpointMedicineHumansSupplemental parenteral nutritioncancergastrointestinal surgeryPharmacology (medical)030212 general & internal medicineeducationWastingDigestive System Surgical ProceduresGastrointestinal NeoplasmsRandomized Controlled Trials as TopicPostoperative Carelcsh:R5-920education.field_of_studybusiness.industryMortality rate030208 emergency & critical care medicineIntensive care unitIntensive Care UnitsParenteral nutritionquality of lifeEmergency medicineDietary SupplementsICUmedicine.symptomlcsh:Medicine (General)businessproteinTrials
researchProduct